Identification of women at high risk of developing endometrial cancer on tamoxifen

European Journal of Cancer

Volumn 36, Issue SUPPL. 4, 2000, Pages

  Berliere M ^a   Radikov, G ^a   Galant, C ^a   Piette, Ph ^a   Marbaix, E ^a   Donnez, J ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; FEMALE; HIGH RISK POPULATION; HUMAN; HYSTEROSCOPY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TRANSVAGINAL ECHOGRAPHY; UTERUS CANCER;

EID: 0033745470     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0959-8049(00)00217-3     Document Type: Article

References (6)

1. Endometrial lesions in patients undergoing tamoxifen therapy
2. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies
3. A realistic clinical perspective of tamoxifen and endometrial carcinogenesis
4. Lack of evidence from HPLC 32P post labelling for tamoxifen DNA adducts in the human endometrium
5. Lack of genotoxicity of tamoxifen in human endometrium
6. Uterine side effects of tamoxifen: A need for systematic pretreatment screening